Brief: Orasure Technologies Receives FDA Clearance For OracollectDx Device For OTC Use
03/11/2022 14:35
Nov 3 (Reuters) - OraSure Technologies Inc OSUR.O :
* ORASURE TECHNOLOGIES RECEIVES GENERAL CLEARANCE FOR ITS
ORACOLLECT®•DX DEVICE FOR OVER-THE COUNTER (OTC) USE FROM THE
U.S. FOOD AND DRUG ADMINISTRATION (FDA)
Source text for Eikon: ID:nGNX4DsqWN
Further company coverage: OSUR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OraSure Technologies
See all newsOraSure Technologies Inc reports results for the quarter ended June 30 - Earnings Summary
OraSure Q2 revenue rises on higher diagnostics sales
Brief: OraSure Technologies Q2 Revenue USD 30.6 Million
OraSure Technologies Inc expected to post a loss of 27 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Wabtec, Chubb, CME Group